Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection

Pediatric Infectious Disease Journal

Volumn 32, Issue 10, 2013, Pages 1050-1054

  Pati, Sunil K ^a   Pinninti, Swetha ^a   Novak, Zdenek ^a   Chowdhury, Nazma ^a   Patro, Raj K ^a   Fowler, Karen ^a   Ross, Shannon ^a,b   Boppana, Suresh ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Congenital infection; Cytomegalovirus; Genotypes; Hearing loss; Mixed infection

Indexed keywords

GLYCOPROTEIN;

ARTICLE; BIRTH; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEARING IMPAIRMENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; SALIVA ANALYSIS; URINE CULTURE;

COHORT STUDIES; COINFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; SALIVA; VIRAL LOAD;

EID: 84891827348     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829bb0b9     Document Type: Article

References (34)

1. Morton CC, Nance WE. Newborn hearing screening - a silent revolution. N Engl J Med. 2006;354: 2151-2164.
2. Dahle AJ, Fowler KB, Wright JD, et al. Longitudinal investigations of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000;11: 283-290.
3. Britt WJ. Cytomegalovirus. In: Reminghton JS, Klein JO, Wilson CB, et al, eds. Infectious Diseases of the Fetus and Newborn Infant. 7th ed. Philadelphia, PA: Elsevier Saunders; 2011: 706-755.
4. Chou SW. Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens. J Infect Dis. 1990;162: 738-742.
5. Coaquette A, Bourgeois A, Dirand C, et al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis. 2004;39: 155-161.
6. Fries BC, Chou S, Boeckh M, et al. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis. 1994;169: 769-774.
7. Murphy E, Yu D, Grimwood J, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A. 2003;100: 14976-14981.
8. Novak Z, Ross SA, Patro RK, et al. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol. 2008;46: 882-886.
9. Pignatelli S, Dal Monte P, Rossini G, et al. Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol. 2003;84(pt 3): 647-655.
10. Puchhammer-Stöckl E, Görzer I, Zoufaly A, et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation. 2006;81: 187-194.
11. Rasmussen L, Geissler A, Cowan C, et al. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol. 2002;76: 10841-10848.
12. Renzette N, Bhattacharjee B, Jensen JD, et al. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 2011;7:e1001344.
13. Lisboa LF, Tong Y, Kumar D, et al. Analysis and clinical correlation of genetic variation in cytomegalovirus. Transpl Infect Dis. 2012;14: 132-140.
14. Manuel O, Asberg A, Pang X, et al. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis. 2009;49: 1160-1166.
15. Ross SA, Novak Z, Pati S, et al. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis. 2011;204: 1003-1007.
16. Boppana SB, Ross SA, Novak Z, et al National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303: 1375-1382.
17. Ross SA, Novak Z, Kumbla RA, et al. GJB2 and GJB6 mutations in children with congenital cytomegalovirus infection. Pediatr Res. 2007;61: 687-691.
18. Boppana SB, Pass RF, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992;11: 93-99.
19. Arav-Boger R, Willoughby RE, Pass RF, et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis. 2002;186: 1057-1064.
20. Yan H, Koyano S, Inami Y, et al. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol. 2008;153: 667-674.
21. Görzer I, Kerschner H, Jaksch P, et al. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections. J Med Virol. 2008;80: 1405-1414.
22. Pang X, Humar A, Preiksaitis JK. Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol. 2008;46: 4004-4010.
23. Boppana SB, Ross SA, Shimamura M, et al National Institute on Deafness and Other Communication Disorders CHIMES Study. Saliva polymerasechain- reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364: 2111-2118.
24. Benedict CA, Butrovich KD, Lurain NS, et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol. 1999;162: 6967-6970.
25. Bodaghi B, Jones TR, Zipeto D, et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med. 1998;188: 855-866.
26. Bale JF Jr, Murph JR, Demmler GJ, et al. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis. 2000;182: 933-936.
27. de Vries JJ, Wessels E, Korver AM, et al. Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes. J Clin Microbiol. 2012;50: 232-237.
28. Yu ZS, Zou CC, Zheng JY, et al. Cytomegalovirus gB genotype and clinical features in Chinese infants with congenital infections. Intervirology. 2006;49: 281-285.
29. Humar A, Kumar D, Gilbert C, et al. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis. 2003;188: 581-584.
30. Sarcinella L, Mazzulli T, Willey B, et al. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol. 2002;24: 99-105.
31. Paradowska E, Studzińska M, Nowakowska D, et al. Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections. Eur J Clin Microbiol Infect Dis. 2012;31: 1335-1345.
32. Waters A, Hassan J, De Gascun C, et al. Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection. J Clin Microbiol. 2010;48: 3956-3962.
33. Arav-Boger R, Battaglia CA, Lazzarotto T, et al. Cytomegalovirus (CMV)- encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis. 2006;194: 464-473.
34. Pignatelli S, Lazzarotto T, Gatto MR, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis. 2010;51: 33-41.